Figure 3From: MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysisGalbraith plots of MDM2 SNP309 polymorphism and endometrial cancer risk in the overall populations (Recessive model GG vs. TG + TT). The study of Zajac et al. was spotted as outlier.Back to article page